Clarivate Plc., a leading global provider of transformative intelligence, has announced the acquisition of the substantial majority of assets of MotionHall, a Silicon Valley technology start-up company serving the life sciences with industry-vertical Artificial Intelligence (AI) solutions.
The acquisition marks a pivotal moment for Clarivate's Life Sciences & Healthcare division, reinforcing its commitment to providing unparalleled intelligence solutions through the integration of cutting-edge AI technologies. By harnessing the power of Generative AI (GenAI) and proprietary industry vertical AI solutions, Clarivate aims to empower its clients with actionable insights that drive innovation and accelerate business success.
"Clarivate is dedicated to delivering transformative intelligence that fuels innovation and drives progress in the life sciences and healthcare sectors," said a spokesperson from Clarivate. "The acquisition of MotionHall aligns seamlessly with our strategic vision, enabling us to enhance our offerings and provide even greater value to our clients."
With the acquisition, Clarivate gains access to MotionHall's full suite of intellectual property, client base, and talented team. This strategic move will facilitate the acceleration of multiple initiatives, including targeted enhancements to Clarivate Cortellis™, a leading platform for life sciences intelligence, as well as the development of a new Business Development & Licensing Enterprise Workbench.
In the immediate future, Clarivate plans to leverage MotionHall's intellectual property to augment Cortellis search capabilities, enrich data quality and coverage, and streamline market assessments for its clients.
Click here to read the original press release.
